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Dear Editor,
We read with great interest the recent article by Moleski 
et  al. [1], discussing symptoms of gluten ingestion in 
patients with Non-Celiac Gluten Sensitivity (NCGS). 
Notably, the authors highlight that without an objective 
marker for NCGS, participants within the study may 
have had alternative gastrointestinal diagnoses. Very lit-
tle has been published about investigating patients with 
NCGS (that self-report symptoms occurring following 
the ingestion of gluten).
It is important to highlight to readers that patients who 
present with either self-reported NCGS or irritable bowel 
syndrome (IBS) ‘type’ symptoms should be investigated 
for other causes for their gastrointestinal symptoms. In 
view of this, we reviewed the case notes of patients with 
self-reported NCGS (n = 205) and with a new presen-
tation of IBS ‘type’ symptoms (n = 74). Patients were 
divided into two groups, group one consisted of indi-
viduals presenting with self-reported NCGS. In con-
trast, group two consisted of individuals with a new 
presentation of IBS ‘type’ symptoms. Individuals were 
characterised according to demographics, in addition to 
investigative outcomes.
We found that patients presenting with NCGS and 
IBS ‘type’ symptoms were predominantly female, at 
84% (n = 172) and 62% (n = 46) respectively. There was 
no significant difference in the presenting age between 
patients (NCGS mean age 40.0 ± 15.7 years vs IBS mean 
age 38.4 ± 14.1  years; p = 0.56). Following investigation, 
11.7% (n = 24) of NCGS and 17.6% (n = 13) of patients 
with IBS ‘type’ symptoms were found to have other gas-
trointestinal diagnosis (Tables  1 and 2). The most com-
mon diagnosis for the NCGS group was celiac disease 
(CD) (8.8%, n = 18) and by comparison for patients with 
IBS ‘type’ symptoms it was bile acid diarrhoea (BAD) 
(13.5%, n = 10).
We conclude that the demographics of patients with 
NCGS and IBS are similar, with a young female presenta-
tion. We found a significant minority of these patients have 
other GI diagnoses. The data supports the recommenda-
tion that patients presenting with self-reported NCGS 
should only be confirmed as having NCGS after exclud-
ing other gastrointestinal disorders. We have also demon-
strated from our data that a similar approach is required 
in patients with IBS ‘type’ symptoms. One strategy that 
may help would be the utilisation of the Salerno experts’ 
criteria in reaching a firm and positive diagnosis of NCGS 
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which would in turn improve the validity of the results 
published [2]. Whilst this approach may be regarded as 
cumbersome, it would facilitate comparison of different 
studies if adopted universally [2]. We fear that until a vali-
dated a biomarker of NCGS is discovered, further research 
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Table 1 Breakdown of the diagnosis of patients presenting with 
self-reported gluten sensitivity
Final primary diagnosis Number 
of patients 
(%)
Non-celiac gluten sensitivity (NCGS) 181 (88.3)
Celiac disease (CD) 18 (8.8)
Fructose intolerance 1 (0.5)
Lactose intolerance 2 (1.0)
Small intestinal bacterial overgrowth (SIBO) 3 (1.5)
Total 205 (100.0)
Table 2 Breakdown of the diagnosis of patients presenting with 
IBS ‘type’ symptoms
Final primary diagnosis Number 
of patients 
(%)
Irritable Bowel Syndrome (IBS) 61 (82.4)
Bile acid diarrhoea (BAD) 10 (13.5)
Microscopic colitis 2 (2.7)
Pancreatic exocrine insufficiency (PEI) 1 (1.4)
Total 74 (100.0)
